Connect Sign In
ARUP Consult, a free online test selection and interpretation tool, added updated information in September that includes preoperative testing guidance for ovarian cancer biomarkers and testing strategies for malaria. |
October 7, 2021 |
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing |
|
September 22, 2021 |
ARUP Expert Explains Factors That Influence COVID-19 Vaccine Effectiveness Although vaccines have not brought the pandemic to its end, they have proven to be a potent tool |
The additional COVID-19 Lab that ARUP has reconstructed to help meet renewed demand performs automated COVID-19 testing by nucleic acid amplification on Roche instrumentation. |
September 10, 2021 |
ARUP Again Ramps Up Testing Operations to Help Fight COVID-19’s Fourth Wave ARUP Laboratories has reconstructed an additional lab dedicated solely to high-throughput COVID-19 molecular |
ARUP experts evaluated an Emergency Use Authorization assay that detects SARS-CoV-2 neutralizing antibodies such as those pictured. |
July 19, 2021 |
Test That Detects SARS-CoV-2 Neutralizing Antibodies May Hold a Key to… A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 |
|
July 14, 2021 |
ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with… GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) |
New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible. |
June 22, 2021 |
ARUP Expert Leads IDSA Panel That Authored New COVID-19 Antigen Testing Guidelines Rapid antigen testing has been used widely during the COVID-19 pandemic to determine infection status |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
